| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 09/01/2009 | CA2452432C Active ingredient combination for the pharmacological therapy of nicotine dependence |
| 09/01/2009 | CA2448689C Percutaneously absorbable patches |
| 09/01/2009 | CA2417727C Fentanyl composition for nasal administration |
| 09/01/2009 | CA2414753C Dermal therapeutic system containing 2-(3-benzophenyl)-propionic acid or [0-(2,6-dichloranilino)-phenyl]-ethanoic acid |
| 09/01/2009 | CA2400804C Stable emulsion compositions of cycloalkene derivatives |
| 09/01/2009 | CA2393344C Methods for making sustained-release pharmaceutical compositions of ergot alkaloids having improved bioavailability and compositions thereof |
| 09/01/2009 | CA2385867C Sustained release form comprising alpha-lipoic acid or derivatives thereof |
| 09/01/2009 | CA2379147C Percutaneously absorbable preparations |
| 09/01/2009 | CA2372231C Aerosol formulations and devices for increasing libido in women via acute testosterone administration |
| 09/01/2009 | CA2370556C Timed dual release dosage forms comprising a short acting hypnotic or a salt thereof |
| 09/01/2009 | CA2272540C Anti-oxidizing composition for scavenging free radicals, pharmaceutical composition comprising the same, and process for preparing the same |
| 09/01/2009 | CA2255657C Solution and process for resuscitation and reparation of ischemically damaged tissue |
| 09/01/2009 | CA2238360C Enzymatic method and compositions for treating intravitreal hemorrhagic blood |
| 08/27/2009 | WO2009105792A1 Nanoparticle carriers for drug administration and process for producing same |
| 08/27/2009 | WO2009105568A1 Composition comprising a combination of omeprazole and lansoprazole, and a buffering agent, and methods of using same |
| 08/27/2009 | WO2009105409A2 Dip coated compositions containing a starch having a high amylose content |
| 08/27/2009 | WO2009105369A1 Sustained release poloxamer containing pharmaceutical compositions |
| 08/27/2009 | WO2009105294A2 Topical compositions and methods for whitening skin |
| 08/27/2009 | WO2009105283A1 Use of immunogenic compositions for the treatment or prevention of pathogen infections |
| 08/27/2009 | WO2009105265A2 Treatment of aneurysm with application of connective tissue stabilization agent in combination with a delivery vehicle |
| 08/27/2009 | WO2009105165A2 Cardioplegia solution for cardiac surgery |
| 08/27/2009 | WO2009105164A2 Blood substitute solution |
| 08/27/2009 | WO2009105130A1 Biomimetic extracellular matrices |
| 08/27/2009 | WO2009105049A1 Oral tablet compositions containing nateglinide and surfactan ph adjusting agent |
| 08/27/2009 | WO2009105023A1 Pharmaceutical formulation comprising oxabispidines / 236 |
| 08/27/2009 | WO2009104988A1 Pharmacological adjuvants based on coordination compounds of d-metals |
| 08/27/2009 | WO2009104963A1 Methods and compositions of sphingolipid for preventing and treating microbial infections |
| 08/27/2009 | WO2009104939A2 Pharmaceutical preparation |
| 08/27/2009 | WO2009104932A2 Composite preparation |
| 08/27/2009 | WO2009104916A2 Pharmaceutical formulations for the treatment of cardiovascular diseases |
| 08/27/2009 | WO2009104838A1 Sustained release solid formulations and methods of manufacturing the same |
| 08/27/2009 | WO2009104822A1 Medical preparation for retinal ischemia disorders, containing hydrogen molecules |
| 08/27/2009 | WO2009104739A1 Solid preparation for oral administration |
| 08/27/2009 | WO2009104738A1 Biomolecule-immobilized carrier and method for immobilizing biomolecule on carrier |
| 08/27/2009 | WO2009104706A1 Microparticles and pharmaceutical compositions thereof |
| 08/27/2009 | WO2009104649A1 Synthetic glycolipid-containing liposomes |
| 08/27/2009 | WO2009104205A1 Delayed release formulation of chloride channel activator |
| 08/27/2009 | WO2009104176A2 Methods of attaching a molecule-of-interest to a microtube |
| 08/27/2009 | WO2009104175A2 Use of electrospun microtubes for drug delivery |
| 08/27/2009 | WO2009104045A1 Ophthalmic gemifloxacin compositions for the treatment of ocular infections |
| 08/27/2009 | WO2009103932A1 Use of a cardiac glycoside and/or a diuretic for the treatment of neuropathic pain |
| 08/27/2009 | WO2009103901A2 Pharmaceutical composition containing an n‑phenylpyrazole derivative and glycofurol, use for the preparation of a topical veterinary medicament for combating fleas |
| 08/27/2009 | WO2009103209A1 Stable s-(-)- nadifloxacin-l-arginine composition, its preparation method and use |
| 08/27/2009 | WO2009086296A3 Counter-pressure filtration of proteins |
| 08/27/2009 | WO2009084017A3 Taste-masked orally disintegrating tablets of memantine hydrochloride |
| 08/27/2009 | WO2009081174A3 Anti - retroviral combination |
| 08/27/2009 | WO2009073941A3 Ternary liposomal composition containing a polynucleotide |
| 08/27/2009 | WO2009058798A3 Orally disintegrated dosage form |
| 08/27/2009 | WO2009004403A3 Burst suppression monitor for induced coma |
| 08/27/2009 | WO2008115979A3 Meltable binder for melt granulation and/or pelletization |
| 08/27/2009 | WO2008115371A3 Amorphous drug transdermal systems, manufacturing methods, and stabilization |
| 08/27/2009 | WO2008113066A3 Ubiquinol and alpha lipoic compositions |
| 08/27/2009 | WO2008081268A3 Pharmaceutical compositions of entacapone |
| 08/27/2009 | WO2008026044A3 Pharmaceutical compositions of bupropion |
| 08/27/2009 | US20090217400 Enzymes, cells and methods for site specific recombination at asymmetric sites |
| 08/27/2009 | US20090215739 Chemical method of making a suspension, emulsion or dispersion of pyrithione particles |
| 08/27/2009 | US20090215713 Use of atp for the manufacture of a medicament for the prevention and treatment of oxidative stress and related conditions |
| 08/27/2009 | US20090215688 GLP-I Agonist And Cardiovascular Complications |
| 08/27/2009 | US20090215009 Medical material, artificial tooth root, and method of producing medical material |
| 08/27/2009 | US20090214719 Dry State Coating Process |
| 08/27/2009 | US20090214667 Medical technical product, method for producing the same and providing the same for surgery |
| 08/27/2009 | US20090214666 Chitin microparticles and their medical uses |
| 08/27/2009 | US20090214665 Controlled Release Muscarinic Receptor Antagonist Formulation |
| 08/27/2009 | US20090214664 Pharmaceutical Dosage Forms Comprising an Active Ingredient Combination of Nifedipine and/or Nisoldipine and an Angiotensini II Antagonist |
| 08/27/2009 | US20090214663 Virus coated nanoparticles and uses thereof |
| 08/27/2009 | US20090214662 Surface-layer protein coated microspheres and uses thereof |
| 08/27/2009 | US20090214661 Process for the production of beadlets |
| 08/27/2009 | US20090214660 Encapsulation system |
| 08/27/2009 | US20090214659 Mineral composition |
| 08/27/2009 | US20090214658 Inorganic sorbent copolymer |
| 08/27/2009 | US20090214657 Orally Absorbed Pharmaceutical Formulation and Method of Administration |
| 08/27/2009 | US20090214656 Itraconazole compositions with improved bioavailability |
| 08/27/2009 | US20090214655 Method and Device for Obtaining Micro and Nanometric Size Particles |
| 08/27/2009 | US20090214654 Treatment of aneurysm with application of connective tissue stabilization agent in combination with a delivery vehicle |
| 08/27/2009 | US20090214653 Bone morphogenetic protein 4 and osteogenic devices and pharmaceutical products containing thereof |
| 08/27/2009 | US20090214652 Soft tissue implants and anti-scarring agents |
| 08/27/2009 | US20090214651 Production of polyurethane foams |
| 08/27/2009 | US20090214650 Methods of Treating alcoholism and alcohol related disorders using combination drug therapy and swellable polymers |
| 08/27/2009 | US20090214649 Scaffolds with oxygen carriers, and their use in tissue regeneration |
| 08/27/2009 | US20090214648 Pharmaceutical formulations comprising ibuprofen and diphenhydramine |
| 08/27/2009 | US20090214647 Compositions For Enternal Application Of Microorganisms |
| 08/27/2009 | US20090214646 Pharmaceutical formulations containing clopidogrel |
| 08/27/2009 | US20090214645 Pharmaceutical compositions comprising a ph-dependent drug, a ph modifier and a retarding agent |
| 08/27/2009 | US20090214644 Tranexamic acid formulations with reduced adverse effects |
| 08/27/2009 | US20090214643 Improved pharmacokinetic profile of beta-adrenergic inverse agonists for the treatment of pulmonary airway diseases |
| 08/27/2009 | US20090214642 Coated formulations for tolterodine |
| 08/27/2009 | US20090214641 Sweetened Capsules for Administration |
| 08/27/2009 | US20090214640 Delayed release pharmaceutical oral dosage form and method of making same |
| 08/27/2009 | US20090214639 Omp p6 vaccine for treating and preventing chlamydia infection |
| 08/27/2009 | US20090214638 Liposome encapsulated poly-iclc method to prophylactically treat an avian influenza viral infection |
| 08/27/2009 | US20090214637 Novel Gene Therapy Approach For Treating The Metabolic Disorder Obesity |
| 08/27/2009 | US20090214636 Imaging and Therapeutic Method Using Monocytes |
| 08/27/2009 | US20090214635 Identification of a conserved region of plasmodium falciparum msp3 targeted by biologically active antibodies |
| 08/27/2009 | US20090214634 Compositions and methods for the treatment of bladder cancer |
| 08/27/2009 | US20090214633 Nanoparticles with lipid core and polymer shell structures for protein drug delivery prepared by nanoencapsulation |
| 08/27/2009 | US20090214632 Inducing cellular immune responses to human papillomavirus using peptide and nucleic acid compositions |
| 08/27/2009 | US20090214631 Process for the Preparation of Strontium Ranelate |
| 08/27/2009 | US20090214630 Compositions and Methods for the Treatment of Inflammatory Bowel Disease Utilizing NF-KappaB Decoy Polynucleotides |
| 08/27/2009 | US20090214629 Gene transfer method |
| 08/27/2009 | US20090214628 Methods and compositions for treatment of skin |